Zhang et al., 2015 - Google Patents
Partially isobaric peptide termini labeling assisted proteome quantitation based on MS and MS/MS signalsZhang et al., 2015
- Document ID
- 12696407127234891604
- Author
- Zhang S
- Wu Q
- Shan Y
- Zhou Y
- Zhang L
- Zhang Y
- Publication year
- Publication venue
- Journal of proteomics
External Links
Snippet
Isotopic labeling and isobaric labeling are two kinds of the typical quantification method that have been widely used in proteomics analysis. Herein, a novel quantitative strategy, partially isobaric peptide termini labeling (PITL), was developed to overcome the drawbacks of each …
- 238000002372 labelling 0 title abstract description 69
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6848—Methods of protein analysis involving mass spectrometry
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/62—Detectors specially adapted therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2458/00—Labels used in chemical analysis of biological material
- G01N2458/15—Non-radioactive isotope labels, e.g. for detection by mass spectrometry
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Rozanova et al. | Quantitative mass spectrometry-based proteomics: an overview | |
Chen et al. | Quantitative proteomics using isobaric labeling: a practical guide | |
Angel et al. | Mass spectrometry-based proteomics: existing capabilities and future directions | |
Evans et al. | An insight into iTRAQ: where do we stand now? | |
Frost et al. | 21-plex DiLeu isobaric tags for high-throughput quantitative proteomics | |
Rauniyar et al. | Isobaric labeling-based relative quantification in shotgun proteomics | |
Xiang et al. | N, N-dimethyl leucines as novel isobaric tandem mass tags for quantitative proteomics and peptidomics | |
Zee et al. | Discovery of lysine post-translational modifications through mass spectrometric detection | |
Messana et al. | Unraveling the different proteomic platforms | |
Zhang et al. | Application of electron transfer dissociation mass spectrometry in analyses of non‐enzymatically glycated peptides | |
US20160097749A1 (en) | Analyte mass spectrometry quantitation using a universal reporter | |
Tian et al. | Chemical isotope labeling for quantitative proteomics | |
Zhou et al. | Recent advances in stable isotope labeling based techniques for proteome relative quantification | |
Liu et al. | Constrained selected reaction monitoring: quantification of selected post-translational modifications and protein isoforms | |
Page et al. | FTICR mass spectrometry for qualitative and quantitative bioanalyses | |
Taverna et al. | A critical comparison of three MS‐based approaches for quantitative proteomics analysis | |
Shah et al. | Tissue proteomics using chemical immobilization and mass spectrometry | |
Tian et al. | A versatile isobaric tag enables proteome quantification in data-dependent and data-independent acquisition modes | |
Schiel et al. | LC-MS/MS biopharmaceutical glycoanalysis: identification of desirable reference material characteristics | |
Frost et al. | In vitro galactation of human serum albumin: Analysis of the protein’s galactation sites by mass spectrometry | |
Frost et al. | Mass defect-based dimethyl pyrimidinyl ornithine (DiPyrO) tags for multiplex quantitative proteomics | |
Zhang et al. | Partially isobaric peptide termini labeling assisted proteome quantitation based on MS and MS/MS signals | |
James et al. | Basic design of MRM assays for peptide quantification | |
Shimada et al. | Development of iodoacetic acid-based cysteine mass tags: Detection enhancement for cysteine-containing peptide by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry | |
Konno et al. | Highly accurate and precise quantification strategy using stable isotope dimethyl labeling coupled with GeLC-MS/MS |